Johnson and Johnson to market Ostex International's NTx assay
This article was originally published in Clinica
Executive Summary
Johnson & Johnson Clinical Diagnostics will market Ostex International's (US) bone resorption assay, Osteomark, in certain countries worldwide. Ostex has also granted J&J a co-exclusive, 10-year licence to adapt and distribute Osteomark for use on J&J's proprietary instrument systems worldwide, except Japan.